Twist Bioscience Corporation
TWST
$120.40
-$4.89-3.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.92% | 6.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.92% | 6.77% | |||
| Cost of Revenue | 4.35% | 7.78% | |||
| Gross Profit | 9.33% | 5.84% | |||
| SG&A Expenses | 6.08% | 9.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.54% | 9.35% | |||
| Operating Income | 6.15% | -17.50% | |||
| Income Before Tax | 21.01% | -45.36% | |||
| Income Tax Expenses | 623.26% | -83.00% | |||
| Earnings from Continuing Operations | 20.38% | -44.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.38% | -44.30% | |||
| EBIT | 6.15% | -17.50% | |||
| EBITDA | 8.14% | -20.14% | |||
| EPS Basic | 21.26% | -42.82% | |||
| Normalized Basic EPS | 6.60% | -20.32% | |||
| EPS Diluted | 21.26% | -42.82% | |||
| Normalized Diluted EPS | 6.60% | -20.32% | |||
| Average Basic Shares Outstanding | 1.14% | 1.02% | |||
| Average Diluted Shares Outstanding | 1.14% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||